Related Experiment Video
Updated: Mar 18, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Propofol Exerted an Anti-Asthmatic Effect by Attenuating Extracellular Matrix Deposition and Viability of Airway
Zhenzhen Chen1, Yanyan Jiang1, Hua Zhang1
1Department of Respiratory and Critical Care Medicine, Zibo Central Hospital, Zibo, China.
Introduction:
Propofol is the preferred anaesthetic for asthma patients due to its bronchodilatory effects, yet its protective mechanisms remain unclear. This study investigated its effects both in vivo and in vitro.
Methods:
An asthmatic mouse model was induced using ovalbumin (OVA). Airway responsiveness, lung histopathology, and inflammatory biomarkers (IgE, IL-4, IFN-γ) were assessed. TGF-β1-stimulated airway smooth muscle (ASM) cells were used for proliferation, migration, and apoptosis assays via MTT, Transwell, and flow cytometry. ECM production was analyzed by immunohistochemistry and immunofluorescence. The SAPK/JNK signaling pathway was evaluated by western blot.
Results:
Propofol dose-dependently attenuated airway hyperresponsiveness and lung histological damage in OVA-induced asthmatic mice, while reversing abnormal inflammatory biomarker expression. In vitro, propofol inhibited ASM cell proliferation and migration and promoted apoptosis. It also suppressed ECM synthesis and restored TIMP-1 expression to rebalance ECM homeostasis. Mechanistically, propofol inhibited SAPK/JNK pathway activation in both in vivo and in vitro models.
Discussion:
These findings clarify the molecular mechanisms underlying Propofol's protective effects, providing a foundation for its potential therapeutic use in asthma treatment.
Related Concept Videos
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: Muscarinic Receptor Antagonists
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Parenteral Anesthetics: Overview

